Enhanced Specificity in Capturing and Restraining Circulating Tumor Cells with Dual Antibody-Dendrimer Conjugates (Q58641789)

2

0 references

Haiyan Dong

3

0 references

Rongli Zhao

4

0 references

Hongning Chen

5

0 references

Weiyu Shen

6

0 references

Patrick J. Sinko

7

0 references

Yewei Zhu

8

0 references

Jichuang Wang

9

0 references

Jingwei Shao

10

0 references

Yu Gao

11

0 references

Fangwei Xie

12

0 references

Lee Jia

Advanced Functional Materials

13

0 references

language of work or name

English

0 references

publication date

21 January 2015

0 references

published in

0 references

volume

25

0 references

issue

8

0 references

page(s)

1304-1313

0 references

cites work

Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Chemotherapy enhances metastasis formation via VEGFR-1-expressing endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Dendrimer-mediated multivalent binding for the enhanced capture of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Biomimetic nanowire coatings for next generation adhesive drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Nanowire substrate-based laser scanning cytometry for quantitation of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Generation and modulation of hepatocellular carcinoma circulating cells: a new experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Inhibition of human hepatocellular carcinoma HepG2 by phthalocyanine photosensitiser PHOTOCYANINE: ROS production, apoptosis, cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

A novel UPLC/MS/MS method for rapid determination of metapristone in rat plasma, a new cancer metastasis chemopreventive agent derived from mifepristone (RU486).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative colorectal cancer patients predict disease recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Detection of disseminated tumor cells in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Specific capture and release of circulating tumor cells using aptamer-modified nanosubstrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Quick-response magnetic nanospheres for rapid, efficient capture and sensitive detection of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Nanotechnology-based intelligent drug design for cancer metastasis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Targeted delivery of dendritic polyglycerol-doxorubicin conjugates by scFv-SNAP fusion protein suppresses EGFR+ cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

The biology of the 17-1A antigen (Ep-CAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Cell surface molecules and their prognostic values in assessing colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Prediction of distant metastases after curative surgery for rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Successful differentiation of mouse neural stem cells on layer-by-layer assembled single-walled carbon nanotube composite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Interfacing silicon nanowires with mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Dendrimer biocompatibility and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Antibody-based therapeutics in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Endocytosis of nanomedicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Effects of the nanostructure of dendrimer/DNA complexes on their endocytosis and gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556

Synthesis, spectral characterization, and in vitro cellular activities of metapristone, a potential cancer metastatic chemopreventive agent derived from mifepristone (RU486).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201403556